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Background

Methods & Design

Obesity-related nonalcoholic fatty liver disease
(NAFLD) is a worldwide health issue that can
lead to liver fibrosis, cirrhosis, and failure
resulting in premature death. Currently, over 90
million people in the U.S. are thought to have
NAFLD. Early detection and intervention are key
to reverse the disease process.
Newer imaging modalities such as the transient
elastography (FibroScan) is a method in which
healthcare providers can detect fibrosis and
cirrhosis, as measured by the amount of liver
stiffness, in individuals with NAFLD. The
purpose of this review was to synthesize the
literature comparing transient elastography
(FibroScan) to invasive and noninvasive
diagnostic techniques for the detection of liver
fibrosis in people with non-alcoholic fatty liver
disease.

Databases including PubMed, CINAHL,
GoogleScholar and Web of Science were
searched for studies published from 2008 to
2019 for a comprehensive review. After
reviewing abstracts, 30 articles met the
inclusion criteria and were included in this
review.

Results

Figure 1. depicts the technique used to measure liver
stiffness via transient elastography. [Reproduced
from Rockey DC. Noninvasive assessment of liver
fibrosis and portal hypertension with transient
elastography. Gastroenterology 2008;134:8–14 with
permission from Elsevier. Image from Kemp W,
Roberts S. Feasibility and performance of the
FibroScan XL probe. Hepatology
2012;55:1308–9]

PICO Question
For patients with non-alcoholic fatty liver disease,
does the use of transient elastography(FibroScan)
reduce the instance of disease by early detection
and management?

Overall, transient elastography (FibroScan) was
found to be a sufficient tool in conjunction and
comparison with invasive and noninvasive
diagnostic techniques for the detection of liver
fibrosis in people with non-alcoholic fatty liver
disease.

Conclusions
New imaging such as transient elastography
(FibroScan) has been used by healthcare
providers to measure liver stiffness. Transient
elastography was found to be a sufficient tool
in the early detection and prevention of
NAFLD.

Nursing Implications
Nurses can have a greater awareness of the
tools used to detect liver stiffness which aides
in the assessment and data collection for
patients with NAFLD. Patient education is key
to the prevention and maintenance of NAFLD.

Frameworks
Search terms used within this rapid systematic
review included “transient elastography”,
“Nonalcoholic fatty liver disease (NAFLD)” and
“FibroScan”. Studies included in this review
used transient elastography to detect fibrosis,
cirrhosis and liver stiffness in individuals with
NAFLD.

Figure 2. displays examples of liver stiffness.
[Reproduced from Castera L, Forns X, Alberti A.

Non-invasive evaluation of liver fibrosis using
transient elastography. J Hepatol 2008;48:835–
47 with permission from Elsevier. Image from
Image from Kemp W, Roberts S. Feasibility and
performance of the FibroScan XL probe. Hepatology

2012;55:1308–9]
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